Newsletter: Vol. 4, No. 2, March 2020

• A Cross-sectional Analysis of Mifepristone, Misoprostol, and Combination Mifepristone-misoprostol Package Inserts Obtained in 20 Countries
  
• Sensitivity and Specificity of Placental Proteins for Gestational Age Screening:An Exploratory Study
  
• A Non-inferiority Study of Outpatient Mifepristone-misoprostol Medical Abortionat 64-70 Days and 71-77 Days of Gestation
  
• Mifepristone Pretreatment Followed by Misoprostol 200mcg Buccal for theMedical Management of Intrauterine Fetal Death at 14-28 Weeks:A Randomized,Placebo-controlled, Double Blind Trial

Read the full eblast.